Panlopase 10000 / 25000 / 40000 Capsules

Panlopase® is a premium Pancreatin Capsule formulation developed to support patients with Exocrine Pancreatic Insufficiency (EPI) by replacing essential digestive enzymes. Available in 10,000, 25,000, and 40,000 lipase unit strengths, Panlopase® helps improve the digestion of fats, proteins, and carbohydrates, promoting better nutrient absorption and gastrointestinal comfort.

Manufactured under stringent international quality standards, Panlopase® is designed for pharmaceutical distributors, healthcare providers, hospitals, and licensing partners across the United States, United Kingdom, United Arab Emirates, and South Africa.

What is Pancreatin?

Pancreatin is a pancreatic enzyme preparation containing:

Lipase – Digests fats

Amylase – Digests carbohydrates

Protease – Digests proteins

These digestive enzymes compensate for reduced pancreatic enzyme production in patients with pancreatic disorders. Pancreatic enzyme replacement therapy is a standard treatment for exocrine pancreatic insufficiency.

Therapeutic Indications

Panlopase® may be prescribed as pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency associated with:

Chronic Pancreatitis

Cystic Fibrosis

Pancreatic Cancer

Pancreatectomy

Gastrointestinal surgery

Obstructive pancreatic disorders

Other causes of pancreatic enzyme deficiency

Treatment decisions should always be made by qualified healthcare professionals according to local prescribing information.

Benefits of Panlopase®

Effective Digestive Support

Provides pancreatic enzymes that assist in normal digestion.

Improved Nutrient Absorption

Supports absorption of essential nutrients from food.

Helps Reduce Digestive Symptoms

May help reduce symptoms associated with pancreatic enzyme deficiency, including:

Fat malabsorption

Steatorrhea

Bloating

Gas

Abdominal discomfort

Nutritional deficiencies

Multiple Strength Options

Available in three dosage strengths to help physicians individualize enzyme replacement therapy.

Enteric-Coated Pellets

Designed to protect enzymes from stomach acid and facilitate release in the small intestine, where digestion primarily occurs.

How Panlopase® Works

After oral administration with meals:

Enteric-coated capsules pass through the stomach.

The coating protects enzymes from gastric acid.

Pellets release enzymes in the small intestine.

Lipase digests fats.

Protease digests proteins.

Amylase digests carbohydrates.

Nutrient digestion and absorption are improved.

Available Strengths

Panlopase® 10000

Suitable for patients requiring lower pancreatic enzyme supplementation.

Features

10,000 Lipase Units

Enteric-coated pellets

Oral capsules

Consistent enzyme delivery

Panlopase® 25000

Designed for patients requiring moderate enzyme replacement.

Features

25,000 Lipase Units

Balanced enzyme activity

Convenient oral dosing

Enteric-coated technology

Panlopase® 40000

High-strength pancreatic enzyme replacement for patients with greater enzyme requirements.

Features

40,000 Lipase Units

High lipase activity

Effective digestive enzyme replacement

Enteric-coated formulation

Quality Manufacturing

Panlopase® is manufactured following internationally recognized pharmaceutical quality systems with emphasis on:

GMP-compliant manufacturing

Quality-controlled production

Batch-to-batch consistency

Stability testing

Regulatory documentation support

International export capabilities

Suitable Global Markets

Panlopase® is available for pharmaceutical partnerships in:

United States

Supporting companies seeking pancreatic enzyme products for regulated healthcare markets.

United Kingdom

Opportunities for private labeling, licensing, and commercial partnerships.

United Arab Emirates

Reliable supply for hospitals, pharmacies, and pharmaceutical distributors.

South Africa

Supporting access to quality pancreatic enzyme replacement products through local distribution partners.

Frequently Asked Questions

What is Panlopase® used for?

Panlopase® is a pancreatic enzyme replacement therapy intended to aid digestion in patients with exocrine pancreatic insufficiency, as prescribed by a healthcare professional.

What strengths are available?

Panlopase® is available in:

10,000 Units

25,000 Units

40,000 Units

How should Panlopase® be taken?

Pancreatic enzyme products are generally taken with meals or snacks. Capsules should be swallowed whole unless otherwise directed by a healthcare professional. Dosing is individualized based on the patient's clinical condition and dietary fat intake.

Who may benefit from pancreatic enzyme replacement therapy?

Patients diagnosed with exocrine pancreatic insufficiency due to conditions such as chronic pancreatitis, cystic fibrosis, pancreatic surgery, or pancreatic cancer may benefit, under medical supervision.

Is Panlopase® available for international distribution?

Yes. Panlopase® is available for pharmaceutical licensing, private labeling, contract manufacturing, and export partnerships, subject to loc